Crowdfunded Journalism

Chemie Grünenthal visit

Lydia Wilkins photo
Lydia WilkinsAachen, Germany
Help fund this trip to Germany to visit Chemie Grünenthal.

What if I told you that the story of Thalidomide-the drug that caused a catastrophe-is still ongoing?

Until its ban in 1961, Thalidomide was licensed for use in the UK; given to pregnant mothers to combat the affects of morning sickness, it left children without arms, without legs. In some cases it affected sight, it affected hearing, it affected hands and feet.

As late as 2013, according to an article by the BBC, people affected were still being born affected in places such as Brazil.

Thalidomide is not a story that’s over.

The UK distributor of the drug, Distillers, were taken to task by The Sunday Times; this left a legacy of compensation, which is administered by the UK trust. Questions are now being asked about the creator of the drug, Chemie Grünenthal; campaigns are focusing on the question of accountability, as well as who is ultimately responsible.

Chemie Grünenthal, the organisation that created Thalidomide, is based in Germany; they have invited me to view historical documents, to meet and interview their experts.

By supporting this project, you are enabling me to investigate the background to the disaster, as well as efforts to support the victims around the world today, through the Chemie Grünenthal Foundation. As well as this, you would also be helping me to develop further content; there are interviews with people affected by Thalidomide, journalists from The Sunday Times, and others to come, via my column. 

#Chemie Grünenthal, #Thalidomide, #Aachen

Risks and Challenges

Chemie Grünenthal may try to influence any resulting coverage, to make it overly positive about them.